HROW Valuation

Harrow Inc

Add to Watchlist

Advanced Chart

46.090

+1.75(3.947%)1D

Overview
Forecast
Valuation
Earnings

HROW Relative Valuation

HROW's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HROW is overvalued; if below, it's undervalued.

Historical Valuation

Harrow Inc (HROW) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.94 is considered Undervalued compared with the five-year average of 67.16. The fair price of Harrow Inc (HROW) is between 53.69 to 70.63 according to relative valuation methord. Compared to the current price of 44.21 USD , Harrow Inc is Undervalued By 17.66%.

Relative Value

Fair Zone

53.69-70.63

Current Price：44.21

17.66%

Undervalued

41.77

Trailing

Forward

18.47

EV/EBITDA

Harrow Inc. (HROW) has a current EV/EBITDA of 18.47. The 5-year average EV/EBITDA is 14.68. The thresholds are as follows: Strongly Undervalued below 5.03, Undervalued between 5.03 and 9.85, Fairly Valued between 19.50 and 9.85, Overvalued between 19.50 and 24.32, and Strongly Overvalued above 24.32. The current Forward EV/EBITDA of 18.47 falls within the Historic Trend Line -Fairly Valued range.

23.20

EV/EBIT

Harrow Inc. (HROW) has a current EV/EBIT of 23.20. The 5-year average EV/EBIT is 38.43. The thresholds are as follows: Strongly Undervalued below -61.79, Undervalued between -61.79 and -11.68, Fairly Valued between 88.54 and -11.68, Overvalued between 88.54 and 138.64, and Strongly Overvalued above 138.64. The current Forward EV/EBIT of 23.20 falls within the Historic Trend Line -Fairly Valued range.

4.94

Harrow Inc. (HROW) has a current PS of 4.94. The 5-year average PS is 3.27. The thresholds are as follows: Strongly Undervalued below 0.90, Undervalued between 0.90 and 2.08, Fairly Valued between 4.45 and 2.08, Overvalued between 4.45 and 5.64, and Strongly Overvalued above 5.64. The current Forward PS of 4.94 falls within the Overvalued range.

20.25

P/OCF

Harrow Inc. (HROW) has a current P/OCF of 20.25. The 5-year average P/OCF is 24.94. The thresholds are as follows: Strongly Undervalued below -9.97, Undervalued between -9.97 and 7.48, Fairly Valued between 42.40 and 7.48, Overvalued between 42.40 and 59.86, and Strongly Overvalued above 59.86. The current Forward P/OCF of 20.25 falls within the Historic Trend Line -Fairly Valued range.

28.48

P/FCF

Harrow Inc. (HROW) has a current P/FCF of 28.48. The 5-year average P/FCF is 44.57. The thresholds are as follows: Strongly Undervalued below -220.89, Undervalued between -220.89 and -88.16, Fairly Valued between 177.30 and -88.16, Overvalued between 177.30 and 310.03, and Strongly Overvalued above 310.03. The current Forward P/FCF of 28.48 falls within the Historic Trend Line -Fairly Valued range.

Harrow Inc (HROW) has a current Price-to-Book (P/B) ratio of 32.79. Compared to its 3-year average P/B ratio of 39.67 , the current P/B ratio is approximately -17.34% higher. Relative to its 5-year average P/B ratio of 29.69, the current P/B ratio is about 10.43% higher. Harrow Inc (HROW) has a Forward Free Cash Flow (FCF) yield of approximately 0.15%. Compared to its 3-year average FCF yield of -0.36%, the current FCF yield is approximately -142.65% lower. Relative to its 5-year average FCF yield of 0.16% , the current FCF yield is about -1.89% lower.

34.08

P/B

Median3y

39.67

Median5y

29.69

0.15

FCF Yield

Median3y

-0.36

Median5y

0.16

Competitors Valuation Multiple

The average P/S ratio for HROW's competitors is 0.00, providing a benchmark for relative valuation. Harrow Inc Corp (HROW) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 30.25%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Phibro Animal Health Corp

Viridian Therapeutics Inc

Loss

4.17%

1.60B

Performance Decomposition

Market capitalization of HROW increased by 2.51% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -69.76 to -161.50.

The secondary factor is the Revenue Growth, contributed 30.25%to the performance.

Overall, the performance of HROW in the past 1 year is driven by P/E Change. Which is more unsustainable.

30.25%

48.94M → 63.74M

Revenue Growth

-159.26%

-13.23 → 7.84

Margin Expansion

131.52%

-69.76 → -161.50

P/E Change

2.51%